在肠道虫感染中的RELMβ:机制和研究进展
Lei Zhang1, Lilin Li2, Le Sun1
1Department of Pathogen Biology and Immunology, School of Basic Medicine, Kunming Medical University, Kunming, Yunnan, 650500, PR China.
Acta tropica
|October 18, 2025
概括
耐药类分子β (RELMβ) 通过加强肠道屏障和调节免疫力,在对抗肠道虫感染方面发挥着关键作用. 了解RELMβ为治疗寄生虫虫感染提供了新的途径.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 寄生虫学的寄生虫学
背景情况:
- 肠道虫感染是影响人类和动物的全球重大健康问题.
- 肠上皮细胞及其分泌物对于宿主对寄生虫的防御至关重要.
- 耐药类分子β (RELMβ),也称为发现在炎症区2 (FIZZ2) 的蛋白质,是由玻璃杯细胞产生的蛋白质,在炎症和免疫中起着已知的作用.
研究的目的:
- 审查在虫感染期间RELMβ的生物特征和表达.
- 突出RELMβ有助于宿主防御肠道虫的多种机制.
- 提供对宿主-寄生虫-表皮相互作用的见解,并为新的治疗策略提供信息.
主要方法:
- 关于RELMβ和虫感染的研究文献综述.
- 在各种感染模型中分析RELMβ表达模式.
- 综合了关于RELMβ在屏障功能,微生物平衡和免疫调节中的作用的数据.
主要成果:
- RELMβ表现出多方面的反虫活动.
- 它提高了肠道屏障的完整性,并调节了肠道微生物群.
- RELMβ在2型免疫驱动的抗寄生虫反应中发挥着重要作用.
结论:
- RELMβ是宿主对肠道虫反应的关键调解者.
- 它的功能包括直接的抗寄生虫作用,屏障强化和免疫调节.
- 了解RELMβ机制为开发针对宿主-寄生虫-微生物群轴的新疗法提供了基础.
相关概念视频
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...


